In Vitro Evaluation of Bis-3-Chloropiperidines as RNA Modulators Targeting TAR and TAR-Protein Interaction

After a long limbo, RNA has gained its credibility as a druggable target, fully earning its deserved role in the next generation of pharmaceutical R&D. We have recently probed the trans-activation response (TAR) element, an RNA stem–bulge–loop domain of the HIV-1 genome with bis-3-chloropiperidines (B-CePs), and revealed the compounds unique behavior in stabilizing TAR structure, thus impairing in vitro the chaperone activity of the HIV-1 nucleocapsid (NC) protein. Seeking to elucidate the determinants of B-CePs inhibition, we have further characterized here their effects on the target TAR and its NC recognition, while developing quantitative analytical approaches for the study of multicomponent RNA-based interactions.

[1]  B. Gatto,et al.  B-CePs as cross-linking probes for the investigation of RNA higher-order structure , 2021, Nucleic acids research.

[2]  B. Gatto,et al.  Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein , 2021, Molecules.

[3]  C. Sheridan.  First small-molecule drug targeting RNA gains momentum , 2021, Nature biotechnology.

[4]  B. Gatto,et al.  Appended Aromatic Moieties in Flexible Bis‐3‐chloropiperidines Confer Tropism against Pancreatic Cancer Cells , 2020, ChemMedChem.

[5]  Amanda E Hargrove,et al.  Small molecule-RNA targeting: starting with the fundamentals. , 2020, Chemical communications.

[6]  Jessica L. Childs-Disney,et al.  Small molecule recognition of disease-relevant RNA structures. , 2020, Chemical Society reviews.

[7]  Hafeez S Haniff,et al.  Target-Directed Approaches for Screening Small Molecules against RNA Targets , 2020, SLAS discovery : advancing life sciences R & D.

[8]  Hafeez S Haniff,et al.  How We Think about Targeting RNA with Small Molecules. , 2020, Journal of medicinal chemistry.

[9]  M. Disney.  Targeting RNA with Small Molecules To Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine. , 2019, Journal of the American Chemical Society.

[10]  A. Hargrove,et al.  Targeting RNA in mammalian systems with small molecules , 2018, Wiley interdisciplinary reviews. RNA.

[11]  G. Caliendo,et al.  Non-Natural Linker Configuration in 2,6-Dipeptidyl-Anthraquinones Enhances the Inhibition of TAR RNA Binding/Annealing Activities by HIV-1 NC and Tat Proteins. , 2018, Bioconjugate chemistry.

[12]  B. Gatto,et al.  Direct and Topoisomerase II Mediated DNA Damage by Bis‐3‐chloropiperidines: The Importance of Being an Earnest G , 2017, ChemMedChem.

[13]  Y. Mély,et al.  Insights into the mechanisms of RNA secondary structure destabilization by the HIV-1 nucleocapsid protein , 2016, RNA.

[14]  B. Gatto,et al.  Synthesis and evaluation of a bis-3-chloropiperidine derivative incorporating an anthraquinone pharmacophore. , 2015, Bioorganic & medicinal chemistry letters.

[15]  B. Gatto,et al.  Bis-3-chloropiperidines containing bridging lysine linkers: Influence of side chain structure on DNA alkylating activity. , 2015, Bioorganic & medicinal chemistry.

[16]  B. Gatto,et al.  Synthesis and DNA Cleavage Activity of Bis‐3‐chloropiperidines as Alkylating Agents , 2014, ChemMedChem.

[17]  J. Darlix,et al.  Structural determinants of TAR RNA-DNA annealing in the absence and presence of HIV-1 nucleocapsid protein , 2011, Nucleic acids research.

[18]  Andrew S. Kohlway,et al.  Noncovalent probes for the investigation of structure and dynamics of protein-nucleic acid assemblies: the case of NC-mediated dimerization of genomic RNA in HIV-1. , 2009, Biopolymers.

[19]  Kevin B. Turner,et al.  Understanding the isomerization of the HIV-1 dimerization initiation domain by the nucleocapsid protein. , 2007, Journal of molecular biology.

[20]  D. Fabris,et al.  Dissecting the protein-RNA and RNA-RNA interactions in the nucleocapsid-mediated dimerization and isomerization of HIV-1 stemloop 1. , 2007, Journal of molecular biology.

[21]  Andrew S. Kohlway,et al.  Mapping noncovalent ligand binding to stemloop domains of the HIV-1 packaging signal by tandem mass spectrometry , 2006, Journal of the American Society for Mass Spectrometry.

[22]  M. Negroni,et al.  Specific interactions between HIV-1 nucleocapsid protein and the TAR element. , 2005, Journal of molecular biology.

[23]  B. Roques,et al.  HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence. , 2002, Journal of Molecular Biology.